Riskpilot← Back to searchSign inGet full accessPharmabotic Nordic A/S
A/SActiveCVR 43526731Baltic Kaj 1Activities of agents involved in the wholesale of other particular products · NACE 4618Est. 20221 employees
Revenue 2025
DKK 1,8M
+4140% vs 2024
EBITDA margin
93.1%
+37904% vs 2024
Equity ratio
78.3%
Financial strength
Net profit 2025
DKK 1,4M
+1569% vs 2024
| Revenue | DKK 1,8M | +4140% |
| EBITDA | DKK 1,7M | +37904% |
| Net profit | DKK 1,4M | +1569% |
| Total assets | DKK 1,9M | +981% |
| Equity | DKK 1,5M | +1652% |
| Employees | 1 | — |
Legal name
Pharmabotic Nordic A/S
CVR number
43526731
Legal form
Aktieselskab
NACE code
4618 · Activities of agents involved in the wholesale of other particular products
Founded
20. september 2022
Share capital
DKK 400.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren alene, to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med butiksindretning, inventar salg og salg af health care produkter, samt dermed beslægtet virksomhed.
Address
Baltic Kaj 1
Phone
+4531411747
Email
Peterjosephsen1@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | -155 | 43 | 1.827 |
| Staff expenses | -344 | -48 | -126 |
| EBITDA | -499 | -4 | 1.700 |
| Depreciation & amort. | -480 | -0 | -0 |
| EBIT | -979 | -4 | 1.700 |
| Net financials | -0 | 0 | 0 |
| Profit before tax | -980 | -4 | 1.700 |
| Tax | -0 | -88 | 307 |
| Net profit | -980 | 84 | 1.394 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 28 | 175 | 1.888 |
| Equity | 1 | 84 | 1.478 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 27 | 90 | 409 |
| Total debt | 27 | 90 | 409 |
EBITDA margin
93.1%
This company
15.8%
Market median
+489% vs market
20232025
Equity ratio
78.3%
This company
38.2%
Market median
+105% vs market
20232025
Return on equity
94.3%
This company
18.4%
Market median
+413% vs market
20232025
Net profit margin
76.3%
This company
8.1%
Market median
+842% vs market
20232025
Asset turnover
0.97×
This company
1.12×
Market median
+13% vs market
20232025
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
20232025
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PJ Management | Management | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2025 | |
| Former (5) | ||
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2023 – 2023 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2024 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CAPS HOLDING ApS
Pharmabotic Nordic A/S Board members of Pharmabotic Nordic A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Josephsen | Management | 0 companies |
| Aksel Martin Andersen | Board of Directors | 0 companies |
| Johan Mossberg | Board of Directors | 0 companies |
| Anne Sofie Josephsen | Board of Directors | 0 companies |
| Steen Aage Bock | Board of Directors | 0 companies |
| Rasmus Josephsen | Board of Directors | 0 companies |
| Martin Romme Larsen | Board of Directors | 0 companies |
| Clifford John Anthony | Board of Directors | 0 companies |